Cases & Deals

  • Home
  • Practices
  • Sunovion establishes global patent portfolio for small molecule drugs for certain CNS disorders and pain

Share

Sunovion establishes global patent portfolio for small molecule drugs for certain CNS disorders and pain

February 2010

Client(s) Sunovion Pharmaceuticals Inc.

Jones Day assists Sunovion Pharmaceuticals Inc. in the establishment of a global patent portfolio related to small molecule drugs for the treatment of certain CNS disorders and pain.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.